Medtech suppliers get new tool for navigating Brazil’s regulatory maze
This article was originally published in Clinica
Medical device manufacturers and distributors in Brazil have a new tool for navigating the regulatory maze that is the Brazilian healthcare industry. Medtech regulatory agency Anvisa, together with the national industrial development agency (ABDI) and the national support service for small and medium-sized enterprises (Sebrae) have published a “Compendium of healthcare regulations on medical devices”, with the promise of offering in a single document every regulation affecting the medtech supplies sector. The document (Compêndio da Legislação Sanit�ria de Dispositivos Médicos) was unveiled during the Hospitalar medtech trade fair, which ended last week in São Paulo, and is available via the Anvisa website (www.anvisa.gov.br).
You may also be interested in...
Business development leaders and venture capital investors spoke at Biocom’s annual partnering conference about what they are seeking in relationships with entrepreneurs and start-ups.
Mylan’s full year 2019 earnings report was its last as an independent company, so the focus was on the coming merger with Pfizer’s Upjohn and growth prospects for the new company, Viatris.
Colgate Zero toothpastes and mouthwashes promote what’s missing; Tom’s of Maine natural personal care expands with prebiotic toothpaste, deodorant and hand soap; Gaia adds hemp to its herbs; and Church & Dwight goes environmentally friendly with VitaFusion Goodness supplements, adds CBD versions to line, too.